New malaria combo aims to stop relapses for good
⭐️ CURE ⭐️
Not yet recruiting
This Phase 2b trial tests whether a new drug, SJ733, combined with tafenoquine can cure P. vivax malaria and prevent it from returning. About 104 adults with uncomplicated malaria will receive different schedules of SJ733 plus tafenoquine, or standard chloroquine plus tafenoquine…
Phase: PHASE2 • Sponsor: R. Kiplin Guy • Aim: ⭐️ CURE ⭐️
Last updated Jun 23, 2026 12:09 UTC